IGF1 and Mental deterioration: This would strengthen central cholinergic acetylation enzyme activity and increase insulin-like growth factor-1 expression, leading to the maintenance of cholinergic nerve function and attenuating cognitive decline as seen in rats with cognitive dysfunction (Mayoral et al., 2015).